1-4 of 4
Lacey R. Royer
Close
Sort by
Journal Articles

Expression of JAK2 V617I Does Not Result in Overt Myeloproliferative Disorder, but Results in Cytokine Hypersensitivity

Stefan Brooks, BS, Samuel B Luty, BS, Hew Yeng Lai, BS, Lacey R Royer, Sarah J Morse, MS, Angela G Fleischman, MDPhD
Journal: Blood
Blood (2014) 124 (21): 3218.
https://doi.org/10.1182/blood.V124.21.3218.3218
Published: 2014
Journal Articles

The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition

Brief Report
Angela G. Fleischman, Julia E. Maxson, Samuel B. Luty, Anupriya Agarwal, Lacey R. Royer, Melissa L. Abel, Jason D. MacManiman, Marc M. Loriaux, Brian J. Druker, Jeffrey W. Tyner
Journal: Blood
Blood (2013) 122 (22): 3628–3631.
https://doi.org/10.1182/blood-2013-06-509976
Published: 2013
Includes: Supplemental data
Journal Articles

Exaggerated Response To Toll-Like Receptor Agonist Contributes To Excessive TNF Production In Myeloproliferative Neoplasm

Angela G. Fleischman, MD, PhD, Samuel B Luty, BS, Michael R Garbati, PhD, J Blair Edmiston, BS, Lacey R Royer, Dorian H LaTocha, BS, Grover C. Bagby, M.D., Brian J. Druker
Journal: Blood
Blood (2013) 122 (21): 4097.
https://doi.org/10.1182/blood.V122.21.4097.4097
Published: 2013
Journal Articles

CSF3R T618I Mouse Bone Marrow Transplant Model Of Neutrophilic Leukemia

Julia E Maxson, PhD, Angela G. Fleischman, MD, PhD, Samuel B Luty, BS, Lacey R Royer, Anupriya Agarwal, Marc M. Loriaux, Brian J. Druker, Jeffrey W. Tyner
Journal: Blood
Blood (2013) 122 (21): 223.
https://doi.org/10.1182/blood.V122.21.223.223
Published: 2013